FDA panel backs Novartis' pioneering new cancer gene therapy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/19/2026

1. KLAR
2. KEYS
3. DVLT
4. EPM
5. PANW
6. HD
7. MRCY
8. EL
9. NAPD
10. LOW

Go back to FDA panel backs Novartis' pioneering new cancer gene therapy
BLUEBIRD BIO (NASDAQ: BLUE) Delayed: 4.97 --0 (-0%)
Previous Close $4.97    52 Week High $95.28 
Open $4.97    52 Week Low $35.37 
Day High $4.97    P/E N/A 
Day Low $4.97    EPS $-1.81 
Volume 180       

(NASDAQ: CNCR) Delayed: 9.02 --0 (-0%)
Previous Close $9.02    52 Week High $31.50 
Open $9.02    52 Week Low $18.23 
Day High $9.02    P/E N/A 
Day Low $9.02    EPS $0.00 
Volume 1,046       

(NASDAQ: JUNO) Delayed: 86.96 --0 (-0%)
Previous Close $86.96    52 Week High $57.82 
Open $10.20    52 Week Low $22.37 
Day High $86.96    P/E N/A 
Day Low $86.96    EPS $0.00 
Volume 1       

(NASDAQ: KITE) Delayed: 179.79 --0 (-0%)
Previous Close $179.79    52 Week High $89.84 
Open $17.44    52 Week Low $38.41 
Day High $179.79    P/E N/A 
Day Low $179.79    EPS $0.00 
Volume 146,685       

NOVEN PHARMACEUTIC (NASDAQ: NOVN) Delayed: 0.09 --0 (-0%)
Previous Close $0.09    52 Week High $23.79 
Open $10.12    52 Week Low $13.73 
Day High $0.09    P/E 0.09 
Day Low $0.09    EPS $1.05 
Volume 1,574,031       

NOVARTIS AG (NYSE: NVS) Delayed: 154.55 --0 (-0%)
Previous Close $154.55    52 Week High $89.15 
Open $154.55    52 Week Low $69.84 
Day High $154.55    P/E N/A 
Day Low $154.55    EPS $0.00 
Volume 8,159